At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIAF bioAffinity Technologies, Inc.
Pre-Mkt 07-20 07:49:34 EDT
0.7037
-0.0081
-1.14%
盘前0.6869
-0.0168-2.39%
07:49 EDT
High0.7171Low0.6901Vol75.11K
Open0.7059D1 Closing0.7118Amplitude3.79%
Mkt Cap4.42MTradable Cap4.32MTotal Shares6.28M
T/O52.83KT/O Rate1.22%Tradable Shares6.14M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Bioaffinity Quarterly Cypath Lung Test Sales Double, up More than 200% Year over Year
Reuters  ·  07-07
Bioaffinity Quarterly Cypath Lung Test Sales Double, up More than 200% Year over Year
Bioaffinity to Join Navref-hosted Webinar on Philips-led US Veterans Lung Screening Program
Reuters  ·  07-01
Bioaffinity to Join Navref-hosted Webinar on Philips-led US Veterans Lung Screening Program
BioAffinity will present preclinical findings on small interfering RNAs
TIPRANKS  ·  06-22
BioAffinity will present preclinical findings on small interfering RNAs
bioAffinity reports positive preclinical data for siRNA therapy targeting squamous, basal skin cancer cells
Reuters  ·  06-22
bioAffinity reports positive preclinical data for siRNA therapy targeting squamous, basal skin cancer cells
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
THOMSON REUTERS  ·  06-22
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
BioAffinity Technologies Closes $3.2 Million Public Offering
MT Newswires Live  ·  06-19
BioAffinity Technologies Closes $3.2 Million Public Offering
bioAffinity Technologies closes USD 3.2 million follow-on offering priced at USD 0.8 per share
Reuters  ·  06-19
bioAffinity Technologies closes USD 3.2 million follow-on offering priced at USD 0.8 per share
bioAffinity Technologies Announces Closing of $3.2 Million Offering
THOMSON REUTERS  ·  06-19
bioAffinity Technologies Announces Closing of $3.2 Million Offering
bioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%
MT Newswires Live  ·  06-17
bioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%
BioAffinity Technologies prices 4M shares at 80c in public offering
TIPRANKS  ·  06-17
BioAffinity Technologies prices 4M shares at 80c in public offering
bioAffinity Technologies prices USD 3.2 million public offering at USD 0.8 per share
Reuters  ·  06-17
bioAffinity Technologies prices USD 3.2 million public offering at USD 0.8 per share
bioAffinity Technologies Announces Pricing of $3.2 Million Offering
THOMSON REUTERS  ·  06-17
bioAffinity Technologies Announces Pricing of $3.2 Million Offering
BioAffinity announces webinar for program to advance veteran lung health
TIPRANKS  ·  06-16
BioAffinity announces webinar for program to advance veteran lung health
bioAffinity Technologies to host veteran lung health screening webinar with Philips, 4DMedical
Reuters  ·  06-16
bioAffinity Technologies to host veteran lung health screening webinar with Philips, 4DMedical
BRIEF-Bioaffinity Technologies - Offers 2.63 Million Shares Of Common Stock - SEC Filing
Reuters  ·  06-13
BRIEF-Bioaffinity Technologies - Offers 2.63 Million Shares Of Common Stock - SEC Filing
bioAffinity Technologies - Offers 2.63 Mln Shares of Common Stock - SEC Filing
THOMSON REUTERS  ·  06-13
bioAffinity Technologies - Offers 2.63 Mln Shares of Common Stock - SEC Filing
bioAffinity Technologies - Assumed Public Offering Price Set at $1.52 per Share - SEC Filing
THOMSON REUTERS  ·  06-13
bioAffinity Technologies - Assumed Public Offering Price Set at $1.52 per Share - SEC Filing
bioAffinity to present CyPath Lung test in Society for Advanced Bronchoscopy webinar
Reuters  ·  06-02
bioAffinity to present CyPath Lung test in Society for Advanced Bronchoscopy webinar
BioAffinity Technologies announces notification of Mexico patent allowance
TIPRANKS  ·  05-27
BioAffinity Technologies announces notification of Mexico patent allowance
bioAffinity Technologies says Mexico allows patent covering CyPath Lung cancer detection methods
Reuters  ·  05-27
bioAffinity Technologies says Mexico allows patent covering CyPath Lung cancer detection methods

Introduction

Company Name.
bioAffinity Technologies, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
Issue price:
--